[1]Molecules,2018,vol.23
[2]Patent:CN108912056,2018,A.Locationinpatent:Paragraph0095;0096;0097;0101
[3]Patent:WO2017/12576,2017,A1.Locationinpatent:Page/Pagecolumn76
[4]JournaloftheAmericanChemicalSociety,1951,vol.73,p.3011
[5]ActaCrystallographica,SectionC:CrystalStructureCommunications,2003,vol.59,p.o4-o8
[6]Patent:WO2008/125839,2008,A2.Locationinpatent:Page/Pagecolumn23;37
[7]Patent:WO2008/125833,2008,A1.Locationinpatent:Page/Pagecolumn29;57
[8]EuropeanJournalofMedicinalChemistry,2020,vol.200
[1]CurrentPatentAssignee:UNIVERSITYOFLONDON;ROCHEHOLDINGAG-WO2008/125839,2008,A2
[1]Bhandari,Sonal;Bhargava,SureshK.;Reddy,T.Srinivasa;Reddy,VelmaGanga;Sakla,AkashP.;Sana,Sravani;Shankaraiah,Nagula;Tokala,Ramya[EuropeanJournalofMedicinalChemistry,2020,vol.200]
[1]CurrentPatentAssignee:ACURASTEM-WO2021/163727,2021,A1Locationinpatent:Page/Pagecolumn185;186;191;
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Two polymorphs, with Z' = 1 and 2, of 2-amino-4-chloro-6-morpholinopyrimidine in P21/c, and 2-amino-4-chloro-6-piperidinopyrimidine, which is isomorphous and almost isostructural with the Z' = 2 polymorph.
Journal: Acta crystallographica. Section C, Crystal structure communications 20030101